期刊文献+

17-β-雌二醇对原代人脐静脉内皮细胞一氧化氮生成的影响 被引量:5

17 β-estradiol enhancing the production of nitric oxide from the primary cultures of human umbilical vein endothelial cells
原文传递
导出
摘要 目的观察17β雌二醇对原代人脐静脉内皮细胞(HUVEC)一氧化氮(NO)生成的影响。方法采用胰蛋白酶灌流消化法培养原代HUVEC,以原代HUVEC为对象,观察不同浓度的17β雌二醇(100nmol/L,30nmol/L,10nmol/L,1nmol/L,0.1nmol/L)作用于原代HUVEC一定时间下NO产量(测代谢产物NO-2),采用Greis反应测定NO-2的量。结果100nmol/L17β雌二醇作用1小时,NO-2即明显增高(P<0.001);30nmol/L的17β雌二醇作用下,4小时起NO-2产量即明显增高(P<0.001);10nmol/L的17β雌二醇作用12小时及1nmol/L的17β雌二醇作用18小时,NO-2产量均有明显增高(P<0.05)。0.1nmol/L的17β雌二醇作用24小时内,NO-2产量与对照组比较无统计学差异(P>0.05)。17β雌二醇作用的阈浓度可能在0.1nmol/L-1nmol/L之间。结论17β雌二醇可促进原代人脐静脉内皮细胞NO的生成,可能为其抑制动脉粥样硬化形成、降低血管阻力的重要机理之一。 Objective To investigate the effects of estrogen on the production of nitric oxide (NO). Methods The primary cultures of human umbilical vein endothelial cells (HUVEC) were harvested by trypsin. Confluent primary cultures of HUVEC were exposed to 17 β estradiol in medium. The production of NO was assessed by Griess reaction. Results Exposure of the cells to 17 β estradiol (1nmol/L, 10nmol/L, 30nmol/L, 100nmol/L) enhanced the production of NO at 18 24 hours, 12 24 hours, 4 24 hours, 1 24 hours respectively ( P <0.01), however, the effect was not observed with 17 β estradiol at 0.1nmol/L within 24 hours.Conclusion 17 β estradiol could enhance the production of NO from the primary cultures of HUVEC. This finding suggests the antiatherosclerotic effect and the reduction of vessel resistance of estrogen.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 1998年第5期386-388,共3页 Chinese Journal of Cardiology
关键词 雌二醇 脐静脉 一氧化氮合成 内皮细胞 estradiol umbilical veins endothelium,vascular nitric oxide
  • 相关文献

同被引文献35

  • 1张林华,刘秉文.一次性密度梯度超速离心分离人血清脂蛋白[J].生物化学与生物物理学报,1989,21(3):257-260. 被引量:116
  • 2石如海,祝善俊,杨映波,冯素珍,徐有奇.冠心病患者内皮细胞损伤后的功能变化及卡托普利的干预作用[J].临床心血管病杂志,1995,11(4):195-198. 被引量:9
  • 3鄂征.组织培养和分子细胞学技术(第二版)[M].北京:北京出版社,1997.125.
  • 4王建国 张振庄.绝经年龄是心血管病死亡的危险因素[J].心血管病学进展,1997,18(2):124-125.
  • 5陈晓鸥.激素替代治疗与心脏疾病[J].心血管病学进展,1998,19(6):378-379.
  • 6刘佩文.雌激素替代疗法提高冠状动脉架桥术后生存率[J].心血管病学进展,1998,19(4):252-252.
  • 71,Ettinger B,FriedmanGD,Bush T,et al. Reduced mortality associated with long-term postmenopausal estrogentherapy. Obstet Gynecol, 1996, 87:6-12.
  • 82,Anderson HV. Estrogen therapy, atherosclerosis, and clinical cardiovascular events.Circulation, 1996,94:1809-1811.
  • 93,Grady D,Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and rolonglife in postmenopausal women. Ann Intern Med, 1992,117:1016-1037.
  • 104,Gerhard M, Ganz P. How do we explain the clinical benefits of estrogen? From beside tobench. Circulation, 1995, 92,5-8.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部